Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Unique Potential of Open Federated Learning in Healthcare

Historically, people have opted into research, shared their health data, or taken part in patient surveys. Data had to be collected in a central location with the consent of the users. These paths keep private information protected but unfortunately, it eliminates a considerable amount of data available. However, with federated learning, it’s possible to…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Historically, people have opted into research, shared their health data, or taken part in patient surveys. Data had to be collected in a central location with the consent of the users. These paths keep private information protected but unfortunately, it eliminates a considerable amount of data available. However, with federated learning, it’s possible to collect confidential information, maintain anonymity, and increase data quality. Intel’s Morgan Andersen spoke with Andrew Lamkin, Software Product Manager, and Patrick Foley, the Lead Architect of OpenFL, to discuss a groundbreaking use case of Open Federated Learning (OFL) and the exciting potential of the model. “This goes a little different than our other technologies at Intel, as it is an open-source one,” said Andersen.

OpenFL is a federated learning model. Google introduced federated learning in 2017 to improve text prediction without taking identifying information from Android users (Open Zone). “The short of it is that federated learning deals with sending the model to where the data resides, out at the edge, instead of sending data to a central place for the purpose of training,” said Foley.

Intel collaborated with the University of Pennsylvania and applied federated learning to healthcare. The use case applied explicitly to brain tumors, identifying the lines of the tumors, and determining which ones were operable and inoperable. The study brought in 71 research institutions from around the world. “these models were able to identify operable tumor regions 33 percent better than a model that was trained on public data alone,” said Foley. The study was instrumental in proving that the model was effective in medical research and that it protected patient information.

Python is at the core of OpenFL. “The project, very early on, had the realization of ‘your main customers are data scientists,’ right? So meeting them where they are and in the tool sets that they work, was really kind of crucial to getting things going and being as fast and sot of as robust as things are today,” said Lamkin.

Python is used widely in deep learning, ideal use for OpenFL. OpenFL also links to Jupiter Notebook, where models are developed. With enough demand, Intel’s OpenFL could grow to work with additional programs.

“There’s really only a few multinational companies that could really attempt to centralize all the data sets. I mean that have a presence in enough hospitals, that have a presence globally, at a global scale to put it all together,” said Lamkin. Five years ago, the option to source data on this scale was impossible.

With OpenFL, researchers have a remarkable ability to develop insights from confidential data in all industries.

Learn more about OpenFL by visiting the OpenFL Github and joining the OpenFL Slack Community or connecting with Andrew Lamkin and Patrick Foley on LinkedIn. Don’t forget to subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Health and Life Sciences at the Edge.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

The Centers for Medicare & Medicaid Services (CMS) has established the Office of Health Technology and Products to integrate AI, interoperability, and digital strategies. This new office aims to enhance efficiency across Medicare, Medicaid, and CHIP programs. By centralizing these efforts, CMS seeks to improve healthcare delivery and outcomes.

  • 01The CMS has launched a new office focusing on AI and interoperability.
  • 02The Office of Health Technology and Products will support Medicare, Medicaid, and CHIP programs.
  • 03Centralizing digital strategies aims to improve healthcare delivery and outcomes.

Aug 1, 2026

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

The Centers for Medicare & Medicaid Services (CMS) has established a new Office of Health Technology and Products. This office assumes over 90 responsibilities to lead federal health IT strategy, focusing on areas like AI, interoperability, and claims modernization.

  • 01CMS's new office centralizes health tech authority, focusing on AI and interoperability.
  • 02The office takes on over 90 responsibilities to modernize claims processes.
  • 03CMS aims to lead federal health IT strategy with its new dedicated office.

Aug 1, 2026

Rebuilding Medicine Around Presence: The Future of Physician House Calls with Dr. Yevhen Pavelko, Founder of Inviah Health

Dr. Yevhen Pavelko, founder of Inviah Health, is advocating for the resurgence of physician house calls. He believes that personal interaction can significantly improve patient care and satisfaction. Inviah Health aims to modernize this traditional approach by integrating advanced medical technology.

  • 01Dr. Yevhen Pavelko supports the revival of physician house calls to improve patient care.
  • 02Inviah Health focuses on integrating advanced technology with traditional house call practices.
  • 03Personal interaction between doctors and patients can enhance care and satisfaction.

Jul 31, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512